호흡곤란 증후군 미숙아에서 동맥관 개존증의 약물 치료 : 경구용 ibuprofen과 indomethacin의 비교 = The pharmacological treatment of patent ductus arteriosus in premature infants with respiratory distress syndrome: oral ibuprofen vs. indomethacin

다국어 초록 (Multilingual Abstract)

Purpose:Indomethacin is widely used for the prophylaxis and treatment of patent ductus arteriosus (PDA); however, it is associated with side effects such as renal failure, intraventricular hemorrhage, and gastrointestinal bleeding. Intravenous ibuprofen has been shown to be as effective as indomethacin in prompting PDA closure. If treatment with oral ibuprofen is as effective as indomethacin, it would have the advantages of greater availability, simpler administration, and lower cost. We conducted this study to compare the efficacy and side effects of indomethacin with those of oral ibuprofen, vis-à-vis on the pharmacological closure of PDA.
Methods:As a randomized double-blind study, 34 preterm infants with respiratory distress syndrome and hemodynamically significant PDA were treated with either intravenous indomethacin or oral ibuprofen. Echocardiography was performed by one cardiologist who was blind to the treatment that any given infant received. The rate of ductal closure, the need for additional drug treatment or surgical ligation, clinical outcome, and the side effects of drug treatment were compared.
Results:Ductal closure occurred in 16 of 18 patients (88.9%) from the indomethacin group and in 14 of 16 patients (87.5%) from the ibuprofen group (P>0.05). Three patients in the indomethacin group and four in the ibuprofen group required a second drug treatment (P>0.05). Three patients (i.e., one patient in the indomethacin group and two in the ibuprofen group) underwent surgical ligation (P>0.05). Between the two groups, there was no significant difference vis-à-vis in side effects or clinical outcome.
Conclusion:Compared to indomethacin, oral ibuprofen has the advantages of simpler administration and lower cost, while being as effective; in addition, there are no differences between the two drug treatments with regards to side effects or clinical outcomes. Therefore, the widespread use of oral ibuprofen should be considered in treating PDA in preterm infants. (Korean J Pediatr 2008;51:956-963)

다국어 초록 (Multilingual Abstract)

Purpose:Indomethacin is widely used for the prophylaxis and treatment of patent ductus arteriosus (PDA); however, it is associated with side effects such as renal failure, intraventricular hemorrhage, and gastrointestinal bleeding. Intravenous ibuprofen has been shown to be as effective as indomethacin in prompting PDA closure. If treatment with oral ibuprofen is as effective as indomethacin, it would have the advantages of greater availability, simpler administration, and lower cost. We conducted this study to compare the efficacy and side effects of indomethacin with those of oral ibuprofen, vis-à-vis on the pharmacological closure of PDA.
Methods:As a randomized double-blind study, 34 preterm infants with respiratory distress syndrome and hemodynamically significant PDA were treated with either intravenous indomethacin or oral ibuprofen. Echocardiography was performed by one cardiologist who was blind to the treatment that any given infant received. The rate of ductal closure, the need for additional drug treatment or surgical ligation, clinical outcome, and the side effects of drug treatment were compared.
Results:Ductal closure occurred in 16 of 18 patients (88.9%) from the indomethacin group and in 14 of 16 patients (87.5%) from the ibuprofen group (P>0.05). Three patients in the indomethacin group and four in the ibuprofen group required a second drug treatment (P>0.05). Three patients (i.e., one patient in the indomethacin group and two in the ibuprofen group) underwent surgical ligation (P>0.05). Between the two groups, there was no significant difference vis-à-vis in side effects or clinical outcome.
Conclusion:Compared to indomethacin, oral ibuprofen has the advantages of simpler administration and lower cost, while being as effective; in addition, there are no differences between the two drug treatments with regards to side effects or clinical outcomes. Therefore, the widespread use of oral ibuprofen should be considered in treating PDA in preterm infants. (Korean J Pediatr 2008;51:956-963)

참고문헌 (Reference)

1 Van Overmeire B, "Treatment of patent ductus arteriosus with ibuprofen" 76 : f179-f184, 1997

2 Coceani F, "The response of the ductus arteriosus to prostaglandins" 51 : 220-225, 1973

3 Van Overmeire B, "The pharmacologic closure of the patent ductus arteriosus" 10 : 177-184, 2005

4 Choi W, "The effects of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants" 49 : 1315-1323, 2006

5 Cotton RB, "Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants" 93 : 647-651, 1978

6 Patel J, "Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus" 47 : 36-42, 2000

7 Fowlie PW, "Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis" 88 : f464-f466, 2003

8 Van Overmeire B, "Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial" 364 : 1945-1949, 2004

9 Sharma PK, "Pharmacokinetics of oral ibuprofen in premature infants" 43 : 968-973, 2003

10 Aranda JV, "Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant" 86 : 289-293, 1997

11 Aly H, "Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study" 24 : 260-270, 2007

12 Cotton RB, "Medical management of small preterm infants with symptomatic patent ductus arteriosus" 92 : 467-473, 1978

13 Drummond WH, "Intensive Care of the Fetus and Neonate. 2nd ed" CV Mosby Co 760-771, 1996

14 Van Bel F, "Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging" 118 : 621-626, 1991

15 Ohlsson A, "Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants" 4 : CD003481-, 2005

16 Shah SS, "Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants" 1 : CD004213-, 2006

17 Weiss H, "Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin" 127 : 466-471, 1995

18 Romagnoli C, "Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates" 67 : 676-683, 2000

19 Edwards AD, "Effects of indomethacin on cerebral haemodynamics in very preterm infants" 335 : 1491-1495, 1990

20 Gersony WM, "Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study" 102 : 895-906, 1983

21 Pezzati M, "Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus" 135 : 733-738, 1999

22 Van Bel F, "Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants" 116 : 965-970, 1990

23 Desfrere L, "Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method" 30 : 121-132, 2005

24 Su PH, "Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants" 45 : 665-670, 2003

25 Stefano JL, "Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation" 143 : 236-239, 1991

26 Heyman E, "Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study" 112 : e354-e358, 2003

27 Gournay V, "Cambonie G, Hascoet JM, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo- controlled trial" 364 : 1939-1944, 2004

28 Chemtob S, "Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets" 21 : 777-784, 1990

29 Coceani F, "Age dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen" 57 : 825-831, 1979

30 Chotigeat U, "A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants" 86 : s563-s569, 2003

31 Van Overmeire B, "A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus" 343 : 674-681, 2000